Yasuhiro Oki

240 papers receiving 10.4k citations

Yasuhiro Oki's Hit Papers

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma 2017 · 593 citations
5930+3+7Years since publication100200300400500

Peers

Yasuhiro Oki
Comparison fields: 5 of 132
  • Pathology and Forensic Medicine 5.6k
  • Genetics 2.5k
  • Hematology 1.6k
  • Oncology 3.7k
  • Neurology 1.3k
Replace Sonali M. Smith with:
Sonali M. Smith United States
Luca Baldini Italy
Alessandro M. Gianni Italy
Michele E. G. Ghielmini Switzerland
Fabrice Jardin France
Fredrick B. Hagemeister United States
Michinori Ogura Japan
Francesc Bosch Spain
Corrado Tarella Italy
Ivana N. Micallef United States
Yasuhiro Oki relative to Sonali M. Smith United States Sonali M. Smith's profile →
Citations per field
00.5×1.5×
Sonali M. Smith · 1×
Citations per year

Countries citing papers authored by Yasuhiro Oki

Since Specialization
Citations

This map shows the geographic impact of Yasuhiro Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Oki more than expected).

Fields of papers citing papers by Yasuhiro Oki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Oki. The network helps show where Yasuhiro Oki may publish in the future.

Co-authors

The 25 scholars most cited alongside Yasuhiro Oki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yasuhiro Oki Line = papers co-authored together Yasuhiro Oki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 251 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
Hit paper breakdown →
2017593
2 2006583
3
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
Hit paper breakdown →
2015334
4
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
Hit paper breakdown →
2016315
5 2014313
6 2005310
7 2009296
8 2014284
9 2017246
10 2015243
11 2014225
12 2014213
13 2017208
14 2011208
15 2013187
16 2015184
17 2011173
18 2016169
19 2006143
20 2009122

About Yasuhiro Oki

Yasuhiro Oki is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Neurology and Hematology, having authored 251 papers that have together received 10.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (163 papers), Viral-associated cancers and disorders (47 papers), Chronic Lymphocytic Leukemia Research (44 papers), CNS Lymphoma Diagnosis and Treatment (35 papers), Histone Deacetylase Inhibitors Research (25 papers), Cutaneous lymphoproliferative disorders research (18 papers), Acute Myeloid Leukemia Research (18 papers) and Lung Cancer Treatments and Mutations (15 papers). The work is most often cited by research in Pathology and Forensic Medicine (5.6k citations), Genetics (2.5k citations), Hematology (1.6k citations), Oncology (3.7k citations) and Neurology (1.3k citations). Yasuhiro Oki has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Jean‐Pierre J. Issa, Anas Younes, Hagop Kantarjian, Michelle A. Fanale, Sattva Swarup Neelapu, Luis Fayad, Nathan Hale Fowler, Jaroslav Jelı́nek, Jorge Enrique Romaguera and Xuelin Huang. Their work appears in journals such as Blood, British Journal of Haematology, International Journal of Radiation Oncology*Biology*Physics, Cancer and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact